Bavarian lands monkeypox vaccine contract with unnamed European country

On Thursday, as more monkeypox cases emerge across Europe, Bavarian Nordic has announced a supply contract with an undisclosed European country for its vaccine Imvanex.

Photo: Philip Davali/Ekstra Bladet, Philip Davali

In the face of a small European outbreak of monkeypox, with the UK, Portugal, and Spain reporting confirmed cases, Bavarian Nordic has signed a contract to supply its vaccine against the infection to an undisclosed country in Europe, the company has announced in a Thursday press release.

According to Bavarian, the first recent monkeypox case was confirmed on May 7 in an individual returning from Nigeria, where the infection is endemic. Since then, more than 20 cases have been confirmed in England, Portugal, and Spain, with more suspected cases being investigated, and one case having been confirmed in the US.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs